METTL3 and cervical cancer: Using the online bioinformatics tools including GEPIA and Kaplan‐Meier plotter, we found that cervical cancer patients with increased expression of Mettl3 (Fig. 8j) and TBP (Fig. 8k) showed reduced disease-free survival (DFS).